NLS PHARMACEUTICS LTD (NLSP) Forecast, Price Target & Analyst Ratings
NASDAQ:NLSP • CH1384053976
Current stock price
0.762 USD
+0.02 (+2.97%)
At close:
1.08 USD
+0.32 (+41.73%)
After Hours:
Analyst forecast overview
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for NLS PHARMACEUTICS LTD (NLSP).
Forecast Snapshot
Price Target Details & History
Consensus Price Target and Range
Mean target
N/A
Upside
N/A
From current price of $0.76 to mean target of N/A, Based on 6 analyst forecasts
Low
N/A
Median
N/A
High
N/A
Price Target Revisions
1 Month
0.00%
3 Months
0.00%
Price Target Summary
Analyst Ratings & History
Current Analyst Ratings
Analyst Ratings History
Analyst Ratings Consensus
ChartMill Buy Consensus
43.33%
NLSP was analyzed by 6 analysts. The buy percentage consensus is at 43. So analysts seem to be rather negative about NLSP.
In the previous month the buy percentage consensus was at a similar level.
NLSP was analyzed by 6 analysts. More opinions would make the average more meaningful.
Recent Upgrades & Downgrades
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2023-09-14 | Maxim Group | Downgrade | Buy -> Hold |
| 2022-12-08 | Maxim Group | Upgrade | Hold -> Buy |
| 2022-11-08 | Maxim Group | Downgrade | Buy -> Hold |
| 2022-09-06 | Laidlaw & Co. | Initiate | Buy |
| 2021-03-12 | Brookline Capital | Initiate | Buy |
| 2021-03-03 | Maxim Group | Initiate | Buy |
Next Earnings Forecast Details
Next Earnings Details
- Release Date
- N/A
Next Earnings Revisions
Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
N/A
EPS (3 Months)
N/A
Next Earnings Summary
Full Analyst Estimates
Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | N/A | |||||||||
| EBITDA YoY % growth | N/A | N/A | N/A | N/A | -11.85M | -15.47M -30.55% | -11.796M 23.75% | -3.633M 69.20% | N/A | |
| EBIT YoY % growth | -5.77M | -3.45M 40.21% | -4.2M -21.74% | -2.3M 45.24% | -11.86M -415.65% | -15.48M -30.52% | -11.807M 23.73% | -3.636M 69.20% | N/A -649.06% | |
| Operating Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EPS YoY % growth | N/A | N/A | N/A | N/A | N/A -958.82% | N/A -1.24% | N/A 93.05% | N/A -5.26% | N/A 97.19% |
All data in USD
Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates
| EPS Q2Q % growth |
|---|
| Revenue Q2Q % growth |
| EBITDA Q2Q % growth |
| EBIT Q2Q % growth |
All data in USD
Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data
Long Term Forward Growth Forecast Summary
Long Term EPS Growth (CAGR)
EPS Next 3 Year
N/A
EPS Next 5 Year
N/A
Long Term Revenue Growth (CAGR)
Revenue Next 3 Year
N/A
Revenue Next 5 Year
N/A
Long Term EBIT Growth (CAGR)
EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A